Zobrazeno 1 - 10
of 25
pro vyhledávání: '"KENICHI NEGISHI"'
Autor:
Bingyang Xue, Yasuyoshi Ishiwata, Yohei Kawano, Hiromitsu Takahashi, Kenichi Negishi, Takao Aoyama, Masashi Nagata
Publikováno v:
Biological and Pharmaceutical Bulletin. 45:1669-1677
Autor:
AYAKO MAEDA-MINAMI, MAIKO HOSOKAWA, YUMI ISHIKURA, ATSUTO ONODA, YOHEI KAWANO, KENICHI NEGISHI, SHUJI SHIMADA, TOMOMI IHARA, MASAO SUGAMATA, KEN TAKEDA, YASUNARI MANO
Publikováno v:
Anticancer Research. 42:3717-3724
An association between leukotriene receptor antagonists (LTRA) and cancer has been previously reported, but the relationship between LTRA use and cancer prevention remains controversial. This study aimed to clarify the cancer-preventive effect of LTR
Autor:
Yohei Kawano, Yuichiro Yamamoto, Masashi Nagata, Shuji Shimada, Yasunari Mano, Masakazu Yamaguchi, Ayako Maeda-Minami, Kenji Kawasumi, Reiko Matsui, Takao Aoyama, Kenichi Negishi, Azusa Kujirai
Publikováno v:
Anticancer Research. 41:5827-5834
BACKGROUND/AIM Recently, the number of patients with cancer receiving outpatient chemotherapy using oral anticancer drugs has increased, but the currently available outpatient cancer chemotherapy is not safer than that available before. The present s
Autor:
Bingyang, Xue, Yasuyoshi, Ishiwata, Yohei, Kawano, Hiromitsu, Takahashi, Kenichi, Negishi, Takao, Aoyama, Masashi, Nagata
Publikováno v:
Biologicalpharmaceutical bulletin. 45(11)
Although paliperidone-related hyperglycemia has been extensively examined, the underlying mechanisms have not yet been elucidated. We investigated the effects of a single intravenous injection of paliperidone (0.2, 0.4, or 0.6 mg/kg) on serum concent
Autor:
Erika Ishijima, Haruka Sato, Haruka Nasu, Hidetaka Suzuki, Kenichi Negishi, Nurfarhana Ferdaos, Ruka Kurono, Kazumi Yoshizawa
Publikováno v:
Cancer Diagn Progn
Background/Aim: Fatigue is the most common symptom in patients with cancer undergoing radiation therapy or cancer chemotherapy. However, cancer-related fatigue remains undertreated and poorly understood. Materials and Methods: Mice were administered
Autor:
Tatsunori Suzuki, Tomoki Nishikawa, Masashi Nagata, Aya Enomoto, Yuuki Akagi, Takao Aoyama, Mai Hoshiko, Kenichi Negishi, Azusa Kujirai, Shuji Shimada, Saeko Nakamura, Emi Tsukada, Yasunari Mano, Satoshi Nakamatsu, Yohei Kawano
Publikováno v:
Biological and Pharmaceutical Bulletin. 44:611-619
Oral anticoagulants (OACs) pose a major bleeding risk, which may be increased or decreased by concomitant medications. To explore medications that affect the bleeding risk of OACs, we conducted a nested case-control study including 554 bleeding cases
Autor:
Masashi Nagata, Kenichi Negishi, Ayano Mori, Satoshi Nakamatsu, Namiki Sakamoto, Takao Aoyama, Yasunari Mano, Yohei Kawano, Maho Katsuyama, Shuji Shimada, Maki Obana
Publikováno v:
Biological and Pharmaceutical Bulletin. 44:238-244
Mirtazapine (MTZ) is a noradrenergic and specific serotonergic antidepressant. MTZ is reportedly associated with an increased risk of bleeding. However, the underlying mechanism remains unclear. In this study, we investigated the antiplatelet effect
Publikováno v:
YAKUGAKU ZASSHI. 139:1107-1110
'Academic Detailing' is an approach to providing doctors with information about medicines based on the latest non-commercial evidence-based data for proper prescription. Overseas, pharmacists have been active as academic detailers. Academic Detailing
Publikováno v:
Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences). 45:88-96
Autor:
Yohei, Kawano, Maki, Obana, Masashi, Nagata, Yasunari, Mano, Maho, Katsuyama, Yuichiro, Yamamoto, Ayako, Maeda-Minami, Kenichi, Negishi, Masamichi, Takagi, Shuji, Shimada, Takao, Aoyama
Publikováno v:
European journal of pharmacology. 917
Mirtazapine (MTZ) is a noradrenergic and specific serotonergic antidepressant that has been associated with an increased risk of bleeding. However, there is insufficient evidence confirming this association. We hypothesised that 5-HT